Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc.

VRCA | NASDAQ
Chart Builder DCF Calculator
$4.67
+$0.18 (+4.01%)
Sep 22, 2026, 12:48 PM ET · Market open

Market Data

Market Cap
$77.13M
Enterprise Value
$67.74M
Beta
1.50
Average Volume
64.91K
Shares Outstanding (Diluted)
21.31M
Shares Change YoY
124.49%
Institutional Ownership
22.43%
Exchange
NASDAQ
ISIN
US92511W2070

Price Performance

Price Change 1M
-2.8%
Price Change 3M
-20.5%
Price Change 6M
-2.8%
Price Change YTD
-45.9%
Price Change 1Y
0.7%
Price Change 3Y
-88.2%
Price Change 5Y
-96.1%
1M CAGR (ann.)
-11.6%
1Y CAGR (ann.)
11.1%
5Y CAGR (ann.)
-48.0%
All-Time CAGR
-35.8%

Valuation

PE Ratio
-2.04
Forward PE
N/A
PEG Ratio
-0.07
Forward PEG
0.07
PS Ratio
2.54
Forward PS
2.00
PB Ratio
17.91
P/FCF Ratio
-3.43
P/Adj. FCF Ratio
-2.87
P/OCF Ratio
-7.13
EV/Sales
2.23
EV/EBIT
-2.47
EV/EBITDA
-2.56
EV/FCF
-3.01
Earnings Yield
-49.0%
FCF Yield
-29.2%
Adj. FCF Yield
-34.9%

Financial Health

Net Cash
$9.39M
Total Debt
$1.81M
Cash & Short-Term Investments
$11.2M
Total Assets
$36.02M
Current Ratio
1.45
Quick Ratio
1.33
Debt / Equity Ratio
0.42
Debt / EBITDA
-0.07
Debt / FCF
-0.08
OCF / Debt
-12.44
Interest Coverage
-7.54
Altman Z-Score
-13.39
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
85.9%
Operating Profit Margin
-92.8%
EBITDA Margin
-88.6%
Net Profit Margin
-102.8%
FCF Margin
-74.2%
Adj. FCF Margin
-88.8%
SBC / Revenue
11.6%
SBC Impact (per share)
-19.6%

Returns

Return on Assets
-86.6%
Return on Equity
-444.4%
Return on Invested Capital
-193.6%
Return on Capital Employed
-207.2%
Return on Tangible Assets
-86.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
52.2%
Revenue CAGR 5Y
20.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
84.9%
EPS CAGR 5Y
22.7%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
48.0%
FCF CAGR 5Y
-2.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
10
EPS Growth Next 3Y
55.0%
Revenue Growth Next 3Y
43.7%
Earnings Date
Nov 12, 2026
EPS Estimate (next Q)
-$0.50
EPS Growth Est (next Q)
1558.1%
Revenue Est (next Q)
$6.41M
Revenue Growth Est (next Q)
-55.3%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$9
Price Target Upside
100.4%

Cash Flow

Operating Cash Flow
$-22.51M
Free Cash Flow
$-22.51M
Adj. Free Cash Flow
$-26.92M
FCF Per Share
-$0.63
OCF Per Share
-$0.63
OCF/S Ratio
-44.0%

Income Statement

Revenue
$30.32M
Gross Profit
$26.04M
Operating Income
$-28.13M
EBITDA
$-26.49M
Net Income
$-31.18M
EPS (Diluted)
-$2.20
Revenue / Employee
$398.96K
Profit / Employee
$-410.3K
Employees
76

© 2026 bestshares.com. All rights reserved.